[HTML] plos.org

[HTML][HTML] COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS …, 2021 - journals.plos.org
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …
被引用次数：12 相关文章
[HTML] nih.gov

[HTML][HTML] COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS …, 2021 - search.ebscohost.com
Background: Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …
[PDF] scienceopen.com

[PDF][PDF] COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS ONE, 2021 - scienceopen.com
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS ONE, 2021 - go.gale.com
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

[引用][C] COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS …, 2021 - ui.adsabs.harvard.edu
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - Plos one, 2021 - europepmc.org
Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLoS ONE, 2021 - edoc.mdc-berlin.de
BACKGROUND: Cardiac injury associated with cytokine release frequently occurs in SARS-
CoV-2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

[引用][C] COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

S Dimai, L Semmler, A Prabhu, H Stachelscheid… - PLOS ONE, 2021 - pure.pmu.ac.at
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of
Canakinumab. — PMU Forschungsportal Zur Hauptnavigation wechseln Zur Suche …